The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.

Prolongation of the reimbursement of VISMED® and VISMED® MULTI in France

The French Ministry of Health prolongued the partial reimbursement of VISMED® and VISMED® MULTI, both containing a sterile solution of preservative-free 0.18% sodium hyaluronate for ophthalmic use in the symptomatic treatment of the Dry Eye.

VISMED® is the only preservative-free sodium hyaluronate-based lubricant eye drops reimbursed in France.



Setting the standard in contact lens comfort

VISLUBE® is a preservative-free contact lens lubricant indicated for sensations of ocular dryness, reduced comfort and blurred vision during hard and soft contact lens wear.

As VISLUBE® has many characteristics similar to those natural tears, it alleviates sensations of eye irritation experienced by contact lens wear.

VISLUBE® is a patented hypotonic formulation that contains 0.18% sodium hyaluronate, a natural polymer which is also present in the structures of human eyes, associated with essential ions.

VISLUBE® is available in boxes of 20 (or 60) single dose units of 0.3 ml.




pdf VISLUBE® leaflet
trb_lock.gif Doctor information

  • English